Earnings News - Candlesense

Xcel Brands, Inc. Announces Second Quarter 2025 Financial Results

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with significant expertise in livestream shopping an...

What is the market’s reaction (price movement, volume) to this earnings release so far? How does the company's earnings per share (EPS) for Q2 2025 compare to the consensus estimate and prior year quarter? What is the outlook for the company's dividend or share repurchase program, if any, based on the Q2 results?

Symbol: XELB

27 days ago

Read more globenewswire

Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights

SALT LAKE CITY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage b...

How does Clene's Q2 2025 financial performance (e.g., R&D spend, SG&A, net loss) compare to consensus expectations and prior quarters? What are the key risks highlighted in the earnings release that could impact the stock's upside or downside? What potential partnership or licensing opportunities could arise from the recent updates, and how would they affect the company's growth outlook?

Symbol: CLNN

27 days ago

Read more globenewswire

QuesTek Announces Strategic First Half 2025 Results

EVANSTON, Ill. and CAMBRIDGE, Mass., Aug. 14, 2025 /PRNewswire/ -- QuesTek Innovations announced today that corporate bookings surged in the first half of 2025, marking a milestone in the company's...

What macroeconomic or industry trends could influence QuesTek's ability to maintain its booking momentum in H2 2025? How will the announced results impact short‑term stock price volatility and trader sentiment? What are the key risks highlighted by management that could affect the sustainability of the booking growth?

Symbol: QK

27 days ago

Innovative Solutions & Support Reports Third Quarter 2025 Results

EXTON, Pa.--(BUSINESS WIRE)--Innovative Solutions & Support, Inc. (Nasdaq: ISSC) ("IS&S" or the "Company"), a leading provider of advanced avionic solutions for commercial, business aviation and mi...

What is the cash flow situation and any planned capital allocation or dividend policy changes? Will the strong results lead to any changes in analyst consensus or target price? How does the company's performance compare to other avionic solution providers in the market?

Symbol: ISSC

27 days ago

Read more businesswire

Zoomd Technologies Reports Strong Second Quarter 2025 Results Led by 40% Revenue Growth

Conference call will be held on August 14, 2025 at 11 AM ET TORONTO, Aug. 14, 2025 /PRNewswire/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (coll...

What is the expected impact on institutional and retail demand for ZOMD shares based on the earnings surprise and sentiment score? How will the reported results affect the company's short‑term technical chart patterns and potential trading strategies (e.g., momentum, breakout, or mean‑reversion)? Did the conference call reveal any macro‑economic or regulatory risks that could impact Zoomd's growth trajectory?

Symbol: ZOMD

27 days ago

OSI Systems Announces Fourth Quarter and Fiscal Year End Conference Call

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, August 21, 2025 at 9:00am PT to discuss its results...

How might the disclosed replay availability timing affect market participants' ability to react to the earnings information? Did the management address any operational challenges, supply chain constraints, or regulatory risks that could affect performance? What guidance, if any, did management give regarding cash flow generation and balance sheet strength?

Symbol: OSIS

27 days ago

Read more businesswire

Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”) today announced its financial results for the second quarte...

Are there any upcoming catalysts (e.g., conference presentations, additional product launches, or FDA meetings) that could move the stock? What impact could this news have on Alpha Cognition’s stock price in the short term (intraday) and medium term (weeks to months)? How does the sentiment score of 70 align with the overall market perception of the stock?

Symbol: ACOG

27 days ago

Read more businesswire

Bath & Body Works to Report Second Quarter Results on August 28, 2025

COLUMBUS, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its second quarter 2025 financial results before market open on Thur...

What key metrics (e.g., same‑store sales, average ticket size, online vs. in‑store sales mix) will be highlighted in the earnings call? Are there any regulatory, legal, or ESG developments that could affect the company’s outlook? What impact could the earnings release have on BBWI’s stock volatility and trading volume?

Symbol: BBWI

27 days ago

Read more globenewswire

Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapie...

Does the update indicate any upcoming catalyst events (e.g., data readouts, FDA meetings) that could drive stock volatility? What is the company's current valuation multiples (PE, EV/EBITDA, price-to-sales) relative to the sector? How might the sentiment score of 30 (neutral/low) influence investor perception and short‑term trading strategies?

Symbol: ADIL

27 days ago

Read more globenewswire

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel d...

What technical chart patterns or volume changes have occurred in ZURA stock around the release of this news? How does the sentiment score (30) translate into market perception, and has sentiment shifted from prior quarters? What are the key risks highlighted in the filing, such as clinical trial delays, safety concerns, or competitive threats?

Symbol: ZURA

27 days ago

Read more businesswire